Berjino, Rhia Joy V.
HRN: 24-87-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2024
CEFUROXIME 750MG (VIAL)
04/13/2024
04/20/2024
IV
400 MG
EVERY 8 HOURS
EMPIRIC
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes